Company Filing History:
3 out of 1,721 
3 out of 1,198 
2 out of 16 Years Active: 2015-2021
Title: **Kuen-Feng Chen: Innovator in Fibrotic Disease Treatment**
Introduction
Kuen-Feng Chen, a prominent inventor based in Taipei, Taiwan, holds a significant portfolio of six patents. His inventions focus primarily on novel approaches to treating fibrotic diseases, showcasing his dedication to advancing medical science and improving patient outcomes.
Latest Patents
Among Kuen-Feng Chen's latest contributions is a groundbreaking patent titled "Method for Ameliorating Fibrosis Using 1-[4-Chloro-3-(Trifluoromethyl)Phenyl]-3-[3-(4-Cyanophenoxy)Phenyl]Urea." This innovative method provides a new application of this compound in the preparation of drugs aimed at treating various fibrotic diseases, including skin sclerosis, cardiac fibrosis, pulmonary fibrosis, hepatic fibrosis, pancreatic fibrosis, and renal fibrosis. Another notable patent involves "Agonists of Protein Tyrosine Phosphatase SHP-1," where he discloses novel compounds with potential SHP-1 agonist activity, paving the way for cancer treatments.
Career Highlights
Kuen-Feng Chen has made considerable contributions to the field of research through his affiliations with reputable institutions. He has worked with National Taiwan University and National Yang Ming Chiao Tung University, both of which have provided him with a platform to develop and refine his innovative ideas. His commitment to research and development has led to the creation of impactful therapies for complex medical conditions.
Collaborations
Throughout his career, Kuen-Feng Chen has collaborated with esteemed colleagues such as Chung-Wai Shiau and Tung-Hung Su. These partnerships have facilitated breakthrough advancements in his work and have been instrumental in achieving substantial progress in the treatment of fibrotic diseases.
Conclusion
Kuen-Feng Chen stands out as a remarkable inventor whose patents reflect his innovative spirit and dedication to addressing significant health challenges. Through his research and collaborations, he continues to influence the medical field and inspire future innovations in the treatment of fibrotic diseases.